• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION NC EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION NC EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 7213
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 03/10/2020
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that shaft break occurred.The 85% stenosed target lesion was located in the averagely tortuous and severely calcified mid right coronary artery.After a staged rotablator, the lesion was dilated with an emerge balloon catheter without issues, but upon removal from the patient's body the shaft then snapped 1/3 from the hub inside the 8fr guide catheter.The wire was pulled back into the guide catheter and snared the broken shaft without removing the guide catheter.The lesion then dilated with a different balloon catheter.A 2.50 x 32 synergy drug-eluting stent was advanced but failed to cross and so another balloon was used to pre-dilate the lesion.The 2.50 x 32 stent was advanced for the second time but the shaft broke at the mid portion of the catheter while advancing into the guide.The stent was pulled out from the guide catheter without removing the device from it.The procedure was completed with a different device.No patient complications were reported and the patient remained stable all throughout the procedure.
 
Event or Problem Description
It was reported that shaft break occurred.The 85% stenosed target lesion was located in the averagely tortuous and severely calcified mid right coronary artery.After a staged rotablator, the lesion was dilated with an emerge balloon catheter without issues, but upon removal from the patient's body the shaft then snapped 1/3 from the hub inside the 8fr guide catheter.The wire was pulled back into the guide catheter and snared the broken shaft without removing the guide catheter.The lesion then dilated with a different balloon catheter.A 2.50 x 32 synergy drug-eluting stent was advanced but failed to cross and so another balloon was used to pre-dilate the lesion.The 2.50 x 32 stent was advanced for the second time but the shaft broke at the mid portion of the catheter while advancing into the guide.The stent was pulled out from the guide catheter without removing the device from it.The procedure was completed with a different device.No patient complications were reported and the patient remained stable all throughout the procedure.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: returned product consisted of an emerge balloon catheter.The shaft, hypotube, tip and balloon were microscopically and visually examined.There were numerous kinks.There was a complete separation at 48cm distal of the strain relief.There was contrast in the inflation lumen and balloon.The balloon was loosely folded.Microscopic inspection revealed tip damage.Inspection of the remainder of the device presented no other damage or irregularities.Product analysis confirmed the reported broken shaft as the hypotube was separated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NC EMERGE
Common Device Name
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key9912491
Report Number2134265-2020-03897
Device Sequence Number3435269
Product Code LOX
UDI-Device Identifier08714729846505
UDI-Public08714729846505
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
K141236
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/14/2021
Device Model Number7213
Device Catalogue Number7213
Device Lot Number0024596638
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/25/2020
Initial Date Received by Manufacturer 03/11/2020
Supplement Date Received by Manufacturer04/06/2020
Initial Report FDA Received Date04/01/2020
Supplement Report FDA Received Date04/29/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-